Consumer — D&A

Business Segments · D&A

Year-over-year, this metric declined by 100.0%, from $95.75M to $0.00. Over 3 years (FY 2021 to FY 2024), Consumer — D&A shows a downward trend with a -100.0% CAGR.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2017
Last reportedQ4 2024
Rolls up toD&A

How to read this metric

Higher levels relative to revenue may indicate an asset-heavy business model or recent significant capital investments that are now being expensed.

Detailed definition

The non-cash expense allocated to the Consumer Health segment to account for the gradual wear and tear of physical asset...

Peer comparison

Standard across all industries; comparable to segment-level D&A reported by any company with distinct operating segments.

Metric ID: jnj_segment_consumer_health_depreciation_and_amortization

Historical Data

4 years
 FY'21FY'22FY'23FY'24
Value$785.00M$759.00M$383.00M$0.00
YoY Change-3.3%-49.5%-100.0%
Range$0.00$785.00M
CAGR-100.0%
Avg YoY Growth-51.0%
Median YoY Growth-49.5%
Current Streak3+ years decline

Frequently Asked Questions

What is Johnson & Johnson's consumer — d&a?
Johnson & Johnson (JNJ) reported consumer — d&a of $0.00 in Q4 2024.
How has Johnson & Johnson's consumer — d&a changed year-over-year?
Johnson & Johnson's consumer — d&a decreased by 100.0% year-over-year, from $95.75M to $0.00.
What is the long-term trend for Johnson & Johnson's consumer — d&a?
Over 3 years (2021 to 2024), Johnson & Johnson's consumer — d&a has grown at a -100.0% compound annual growth rate (CAGR), from $785.00M to $0.00.
What does consumer — d&a mean?
The periodic cost assigned to the wear and tear of assets used by the Consumer Health segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Johnson & Johnson (JNJ) Consumer — D&A — Quarterly & Annual | OpenCapital